Increased risk of noninfluenza respiratory virus infections associated with receipt of inactivated influenza vaccine.
Ontology highlight
ABSTRACT: We randomized 115 children to trivalent inactivated influenza vaccine (TIV) or placebo. Over the following 9 months, TIV recipients had an increased risk of virologically-confirmed non-influenza infections (relative risk: 4.40; 95% confidence interval: 1.31-14.8). Being protected against influenza, TIV recipients may lack temporary non-specific immunity that protected against other respiratory viruses.
SUBMITTER: Cowling BJ
PROVIDER: S-EPMC3404712 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA